Pfizer Can't Shake Off-Label Marketing FCA Suit
A Pennsylvania federal judge on Wednesday denied Pfizer Inc.'s bid to dismiss a False Claims Act suit alleging the company pushed illegal off-label use of its anti-fungal medication Vfend, ruling the...To view the full article, register now.
Already a subscriber? Click here to view full article